BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
90.36
+2.57 (2.93%)
At close: May 20, 2026, 4:00 PM EDT
91.07
+0.71 (0.79%)
Pre-market: May 21, 2026, 4:37 AM EDT

BioNTech SE Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
22,85123,92627,34525,08936,53562,523
Market Cap Growth
-5.98%-12.50%8.99%-31.33%-41.57%217.54%
Enterprise Value
7,3966,72310,1047,00621,63860,359
Last Close Price
90.3695.20113.95105.54150.22257.80
PE Ratio
---24.933.715.72
Forward PE
---67.818.278.07
PS Ratio
7.066.689.095.781.972.90
PB Ratio
1.061.061.351.121.704.62
P/TBV Ratio
1.181.201.411.261.875.63
P/FCF Ratio
31.0772.60-4.432.5772.14
P/OCF Ratio
24.3044.72126.534.232.5161.80
EV/Sales Ratio
2.291.883.361.621.172.80
EV/EBITDA Ratio
---7.251.583.46
EV/EBIT Ratio
---9.181.603.47
EV/FCF Ratio
10.0620.40-1.241.5269.64
Debt / Equity Ratio
0.010.010.010.010.010.01
Debt / EBITDA Ratio
---0.250.020.02
Debt / FCF Ratio
0.480.95-0.040.020.40
Net Debt / Equity Ratio
-0.77-0.76-0.85-0.81-0.69-0.15
Net Debt / EBITDA Ratio
13.1914.2916.26-18.69-1.08-0.11
Net Debt / FCF Ratio
-22.66-52.01209.76-3.19-1.05-2.33
Asset Turnover
0.130.140.130.170.892.09
Inventory Turnover
5.873.261.691.506.3610.28
Quick Ratio
8.607.387.249.047.194.15
Current Ratio
8.807.547.459.437.434.33
Return on Equity (ROE)
-6.60%-5.88%-3.36%4.62%59.06%155.18%
Return on Assets (ROA)
-7.67%-6.82%-5.67%2.34%47.09%115.21%
Return on Invested Capital (ROIC)
-27.02%-26.18%-23.44%7.48%83.22%145.67%
Return on Capital Employed (ROCE)
-7.91%-7.05%-6.42%3.35%77.38%217.38%
Earnings Yield
---4.01%26.97%17.48%
FCF Yield
3.22%1.38%-22.57%38.90%1.39%
Dividend Yield
-0.00%0.00%0.00%1.42%0.00%
Payout Ratio
-0.00%0.00%0.00%5.13%0.00%
Buyback Yield / Dilution
-1.91%-0.54%0.95%2.84%3.81%-4.51%
Total Shareholder Return
-1.91%-0.54%0.95%2.84%5.23%-4.51%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q